- Home
- PULM vs GRF Comparison
PULM vs GRF Comparison
Compare PULM & GRF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PULM
- GRF
- Stock Information
- Founded
- PULM 2003
- GRF 1989
- Country
- PULM United States
- GRF United States
- Employees
- PULM N/A
- GRF N/A
- Industry
- PULM Biotechnology: Pharmaceutical Preparations
- GRF Finance/Investors Services
- Sector
- PULM Health Care
- GRF Finance
- Exchange
- PULM Nasdaq
- GRF Nasdaq
- Market Cap
- PULM 33.2M
- GRF 38.9M
- IPO Year
- PULM N/A
- GRF N/A
- Fundamental
- Price
- PULM $6.53
- GRF $9.90
- Analyst Decision
- PULM
- GRF
- Analyst Count
- PULM 0
- GRF 0
- Target Price
- PULM N/A
- GRF N/A
- AVG Volume (30 Days)
- PULM 63.0K
- GRF 3.0K
- Earning Date
- PULM 08-12-2025
- GRF 01-01-0001
- Dividend Yield
- PULM N/A
- GRF 3.70%
- EPS Growth
- PULM N/A
- GRF N/A
- EPS
- PULM N/A
- GRF 1.16
- Revenue
- PULM $1,921,000.00
- GRF N/A
- Revenue This Year
- PULM N/A
- GRF N/A
- Revenue Next Year
- PULM $134.88
- GRF N/A
- P/E Ratio
- PULM N/A
- GRF $8.15
- Revenue Growth
- PULM N/A
- GRF N/A
- 52 Week Low
- PULM $1.78
- GRF $7.93
- 52 Week High
- PULM $10.40
- GRF $10.19
- Technical
- Relative Strength Index (RSI)
- PULM 41.09
- GRF 55.53
- Support Level
- PULM $6.51
- GRF $9.72
- Resistance Level
- PULM $7.00
- GRF $9.90
- Average True Range (ATR)
- PULM 0.89
- GRF 0.08
- MACD
- PULM -0.16
- GRF 0.01
- Stochastic Oscillator
- PULM 44.16
- GRF 90.00
About PULM Pulmatrix Inc.
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).
About GRF Eagle Capital Growth Fund Inc.
Eagle Capital Growth Fund Inc is a diversified closed-end investment company. The fund's objective is long-term growth utilizing the concept of total return for selecting investments. It seeks to achieve its investment objectives by investing predominantly in U.S. issuer common stock by giving preference to high-quality companies, where high quality denotes substantial operating income margins, high returns on capital, and robust balance sheets.